LIMA1 and hepatocellular carcinoma: In addition, they demonstrated that EPLIN functioned as an inhibitor of the Wnt/β-catenin signaling pathway through the interaction with BMI1 [76], a proto-oncogene contributing to the malignancy of HCC [77].